Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing

The primary objective of this study is to evaluate the capacity of concentration-guided sorafenib dosing protocols to increase the proportion of patients that achieve a sorafenib maximal concentration (C(max)) within the range 4.78 to 5.78 μg/mL. A full physiologically based pharmacokinetic model wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruanglertboon, Warit, Sorich, Michael J., Hopkins, Ashley M., Rowland, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143107/
https://www.ncbi.nlm.nih.gov/pubmed/33919091
http://dx.doi.org/10.3390/ph14050389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143107/
https://www.ncbi.nlm.nih.gov/pubmed/33919091
http://dx.doi.org/10.3390/ph14050389

Ejemplares similares